Literature DB >> 21736598

Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease.

J-F Rahier1, S De Beauce, L Dubuquoy, E Erdual, J-F Colombel, A Jouret-Mourin, K Geboes, P Desreumaux.   

Abstract

BACKGROUND: Involvement of the lymphatic system in inflammatory bowel disease (IBD) has been suggested. AIMS: To examine the density and distribution of lymphatic vessels (LV) within inflamed and non-inflamed wall sections of IBD patients compared with controls, and to evaluate expression of major lymphangiogenic factors.
METHODS: Ileal and colon specimens of 22 patients with Crohn's disease (CD), 16 patients with ulcerative colitis (UC) and 11 controls were studied. Quantification of LV was performed using immunohistochemistry with podoplanin and D2-40 antibodies on seven randomly selected fields. Mucosal expression of podoplanin and lymphangiogenic factor mRNA was measured using PCR.
RESULTS: In CD patients, lymphatic density was significantly increased in non-inflamed and inflamed ileal (P < 0.01 and P < 0.001) and colonic (P < 0.01 and P < 0.001) mucosa compared to controls. Podoplanin mRNA levels were similar in non-inflamed mucosal areas and controls, whereas a four- and sixfold increase was seen in inflamed ileal and colonic areas (P < 0.05). In UC, lymphatic density increased fourfold in non-inflamed (P < 0.001) and fivefold in inflamed colonic mucosa (P < 0.001) compared with controls. An increase in podoplanin mRNA levels was seen in both non-inflamed and inflamed areas (P < 0.01) compared with controls. In CD and UC, lymphatics were found throughout the inflamed mucosa, including the upper half of the lamina propria. Expression of lymphangiogenic factors was similar in patients and controls.
CONCLUSIONS: Increased density of lymphatic vessels is a constant feature of IBD and is present in non-inflamed areas. It is transmural in CD and confined to the mucosa in UC. Its origin remains unclear.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21736598     DOI: 10.1111/j.1365-2036.2011.04759.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  37 in total

1.  TNFΔARE Mice Display Abnormal Lymphatics and Develop Tertiary Lymphoid Organs in the Mesentery.

Authors:  Sonia Rehal; Pierre-Yves von der Weid
Journal:  Am J Pathol       Date:  2017-02-06       Impact factor: 4.307

Review 2.  Lymphatic pumping: mechanics, mechanisms and malfunction.

Authors:  Joshua P Scallan; Scott D Zawieja; Jorge A Castorena-Gonzalez; Michael J Davis
Journal:  J Physiol       Date:  2016-08-02       Impact factor: 5.182

3.  Lymphoid Aggregates Remodel Lymphatic Collecting Vessels that Serve Mesenteric Lymph Nodes in Crohn Disease.

Authors:  Gwendalyn J Randolph; Shashi Bala; Jean-François Rahier; Michael W Johnson; Peter L Wang; ILKe Nalbantoglu; Laurent Dubuquoy; Amélie Chau; Benjamin Pariente; Alex Kartheuser; Bernd H Zinselmeyer; Jean-Frederic Colombel
Journal:  Am J Pathol       Date:  2016-10-13       Impact factor: 4.307

Review 4.  Inflammation-induced lymphangiogenesis and lymphatic dysfunction.

Authors:  Shan Liao; Pierre-Yves von der Weid
Journal:  Angiogenesis       Date:  2014-01-22       Impact factor: 9.596

5.  Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease.

Authors:  S Anand Narayanan; Corinne E Metzger; Susan A Bloomfield; David C Zawieja
Journal:  FASEB J       Date:  2018-03-29       Impact factor: 5.191

6.  Lymphangiogenesis is induced by mycobacterial granulomas via vascular endothelial growth factor receptor-3 and supports systemic T-cell responses against mycobacterial antigen.

Authors:  Jeffrey Harding; Anna Ritter; Aditya Rayasam; Zsuzsanna Fabry; Matyas Sandor
Journal:  Am J Pathol       Date:  2015-02       Impact factor: 4.307

7.  Lymphatic deletion of calcitonin receptor-like receptor exacerbates intestinal inflammation.

Authors:  Reema B Davis; Daniel O Kechele; Elizabeth S Blakeney; John B Pawlak; Kathleen M Caron
Journal:  JCI Insight       Date:  2017-03-23

8.  Obstructive Lymphangitis Precedes Colitis in Murine Norovirus-Infected Stat1-Deficient Mice.

Authors:  Audrey Seamons; Piper M Treuting; Stacey Meeker; Charlie Hsu; Jisun Paik; Thea Brabb; Sabine S Escobar; Jonathan S Alexander; Aaron C Ericsson; Jason G Smith; Lillian Maggio-Price
Journal:  Am J Pathol       Date:  2018-05-18       Impact factor: 4.307

9.  Endogenous Specialized Proresolving Mediator Profiles in a Novel Experimental Model of Lymphatic Obstruction and Intestinal Inflammation in African Green Monkeys.

Authors:  Felix Becker; Emily Romero; Jason Goetzmann; Dana L Hasselschwert; Beth Dray; John Vanchiere; Jane Fontenot; J Winny Yun; Paul C Norris; Luke White; Melany Musso; Charles N Serhan; J Steven Alexander; Felicity N E Gavins
Journal:  Am J Pathol       Date:  2019-10       Impact factor: 4.307

10.  VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease.

Authors:  Silvia D'Alessio; Carmen Correale; Carlotta Tacconi; Alessandro Gandelli; Giovanni Pietrogrande; Stefania Vetrano; Marco Genua; Vincenzo Arena; Antonino Spinelli; Laurent Peyrin-Biroulet; Claudio Fiocchi; Silvio Danese
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.